Structural and Functional Changes in Neuronal Intranuclear Inclusion Disease(NIID)
NCT ID: NCT04055857
Last Updated: 2019-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2018-07-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Natural History of Multiple Sclerosis and Its Mimickers
NCT02504840
Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease
NCT00249080
Magnetic Resonance Imaging to Detect Brain Damage in Patients With Multiple Sclerosis
NCT00393588
Neuromelanin MRI: A Progression Marker in Early PD
NCT05631158
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NIID
NIID patients
There is no Intervention.
HC
healthy control
There is no Intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
There is no Intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Older than 18 years;
3. Sign the informed consent form.
Exclusion Criteria
2. Contraindications or intolerance to MRI: metallic foreign bodies, instability of vital signs, epilepsy, claustrophobia, etc.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhejiang University Interdisciplinary Institute of Neuroscience and Technology
UNKNOWN
First Affiliated Hospital of Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ruiliang Bai, Doctor
Role: PRINCIPAL_INVESTIGATOR
Zhejiang University Interdisciplinary Institute of Neuroscience and Technology (ZIINT)
Hui Liang, Doctor
Role: PRINCIPAL_INVESTIGATOR
Zhejiang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Siemens 7T MR
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ming Xiong
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7TMRINIID
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.